Research and Markets: Hereditary Angioedema (HAE) Therapeutics Pipeline Review, H1 2015 - 10 Companies & 13 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/n9ngzz/hereditary) has announced the addition of the "Hereditary Angioedema (HAE) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Hereditary Angioedema (HAE), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hereditary Angioedema (HAE) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • BioCryst Pharmaceuticals, Inc.
  • Cevec Pharmaceuticals GmbH
  • CSL Limited
  • Dyax Corp.
  • Global Blood Therapeutics, Inc.
  • iBio, Inc.
  • Isis Pharmaceuticals, Inc.
  • Pharming Group N.V.
  • Ra Pharmaceuticals, Inc.
  • Shire Plc

Drug Profiles

  • BCX-4161
  • BCX-7353
  • BEL-0215
  • C1 esterase inhibitor (human)
  • C1 esterase inhibitor (recombinant)
  • CSL-312
  • DX-2930
  • icatibant acetate
  • ISIS-PKKRx
  • Recombinant Protein to Inhibit C1-esterase for Hereditary Angioedema
  • Small Molecule 2 to Inhibit Plasma Kallikrein for Hereditary Angioedema
  • Small Molecule for Hereditary Angioedema
  • Synthetic Peptide to Inhibit Kallikrein for Hereditary Angioedema

For more information visit http://www.researchandmarkets.com/research/n9ngzz/hereditary

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders